4.10.14.4Vertical

Stroke & Cerebrovascular Programs

Programs treating acute stroke and cerebrovascular disease.

Market snapshot

These figures describe Neurology & Neurosurgery (4.10.14), the segment that Stroke & Cerebrovascular Programs sits within — not Stroke & Cerebrovascular Programs on its own.

FragmentationFragmentedEstimate

Within Offices of Physicians (NAICS 621111); the Census Bureau does not split physician offices by specialty, so neurology is not separately sized.

Business model & economics

Revenue model

Office, diagnostic, and infusion reimbursement

Key economics

Recurring revenue
Moderate

chronic neurological care recurs

EBITDA margin
15–25%
Capex intensity
Low

Characteristics

  • Aging and neurodegenerative disease drive demand.
  • Infusion and diagnostics as ancillary opportunities.
  • Less consolidated than procedure-rich specialties.

M&A deal context

Deal activityModerate

Who’s acquiring

  • Emerging neurology MSO platforms
  • Multispecialty groups
  • Infusion-aligned acquirers

What’s driving deals

  • Emerging neurology consolidation.
  • Aging and chronic-disease demand.
  • Biologic-infusion ancillary economics.

Find Stroke & Cerebrovascular Programs acquisition targets

Search Acquisera’s index for companies classified under Stroke & Cerebrovascular Programs (4.10.14.4) and build a targeted deal pipeline.

Search companies